Pharmacology Book

Metabolic Disorders

  • Drug Activity in Women


Drug Activity in Women

Aka: Drug Activity in Women, Gender-Based Differences in Drug Actvity, Sex-Based Differences in Drug Actvity, Pharmacokinetic Differences based on Gender
  1. Physiology: Pharmacokinetics
    1. Absorption
      1. Alcohol absorption is greater in women (same amount of Alcohol results in higher blood Alcohol level)
      2. Lower gastric pH decreases absorption in women (e.g. Ketoconazole)
      3. Slower gastrointestinal transit time decreases absorption in women
        1. Examples: Metoprolol, Theophylline, Verapamil
      4. Women should wait longer to eat after taking medications directed to be on an empty Stomache
        1. Examples: Amoxicillin, Levothyroxine, Tetracycline
    2. Distribution
      1. Women have lower Body Mass Index and results in lower medication loading doses
        1. Examples: Antiarrhythmics, Aminoglycosides, Digoxin
      2. Women have higher body fat amounts
        1. Lipophilic medications have longer duration of action (e.g. Benzodiazepines, neuromuscular blockers)
        2. Hydrophilic medications have smaller volumes of distribution and reach high concentrations faster (e.g. Alcohol, Fluoroquinolones)
    3. Metabolism
      1. Phase I: Women require less Warfarin per week (by as much as 4.5 mg per week) than men due to differences in metabolism
      2. Phase 2: Typically slower in women for medications such as Acetaminophen, Digoxin, Levodopa
    4. Excretion
      1. Glomerular Filtration Rate is as much as 25% slower in women
      2. Renal excreted medications such as Digoxin, Methotrexate, Aminoglycosides, Fluoroquinolones are cleared more slowly in women
  2. Physiology: Pharmacodynamics - Specific differences among medication classes
    1. Psychiatric medications
      1. Women respond better to Selective Serotonin Reuptake Inhibitors than Tricyclic Antidepressants
      2. Women respond more to typical Antipsychotic Medications (e.g. Haloperidol) than men
    2. Opioid Analgesics
      1. Women have a greater Opioid response for both analgesia and Sedation than men (start with dose 30-40% lower than for men)
    3. Cardiovascular medications
      1. Aspirin has poor platelet inhibition, CVA and MI prevention in women compared with men
      2. Digoxin is associated with increased mortality in women (target a lower dose if used in women)
      3. Beta Blockers lower Blood Pressure and Heart Rate to a greater extent in women than men (especially during Exercise)
  3. Adverse Effects
    1. QT Prolongation
      1. Women have a longer QT Interval than men at baseline
  4. References
    1. Schwartz (2007) Clin Pharmacol Ther 82(1): 87-96 [PubMed]
    2. Schwartz (2003) Clin Pharmacokinet 42(2): 107-21 [PubMed]
    3. Whitley (2009) Am Fam Physician 80(11): 1254-8 [PubMed]

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree